Engaging global experts on particular diseases, involving finance ministers at an early stage, and sharing knowledge and best practice – these were the main recommendations of research by management consultants McKinsey on speeding up the adoption of vaccines in developing countries. The research, first published in McKinsey Quarterly on 5 August, looked at the introduction of vaccine programmes in Egypt, Mauritania, Mexico and Zambia. Only Mexico actively engaged global experts on the disease they were targeting.
Subscribe now from only £45 a year!
This article is only available for our subscribers
Existing users can login here